Data is not available at this time.
Yamada Corporation operates as a specialized industrial and automotive equipment manufacturer, serving both domestic and international markets. The company’s core revenue model is driven by the production and sale of high-precision fluid control systems, including pneumatic, hydraulic, and electric pumps, alongside complementary products like measuring instruments and cleaning equipment. Its diversified portfolio caters to industries requiring precision fluid handling, such as automotive, medical, and industrial manufacturing, positioning it as a niche player with technical expertise. Yamada’s market position is reinforced by its long-standing reputation, dating back to 1905, and its ability to integrate imported medical equipment into its offerings, enhancing its value proposition. While competition in industrial machinery is intense, the company’s focus on reliability and after-sales support provides a defensible edge. Its headquarters in Tokyo and global sales footprint further underscore its strategic reach within the industrials sector.
In FY2023, Yamada reported revenue of ¥14.1 billion, with net income reaching ¥1.81 billion, reflecting a robust net margin of approximately 12.8%. Operating cash flow stood at ¥1.84 billion, supported by efficient working capital management. Capital expenditures of ¥401 million indicate moderate reinvestment, aligning with its steady growth strategy. The company’s profitability metrics suggest disciplined cost control and operational leverage.
Diluted EPS of ¥756.43 highlights strong earnings power, while the low beta of 0.13 implies resilience to market volatility. The company’s capital efficiency is evident in its ability to generate substantial cash flows relative to its debt levels, with operating cash flow covering total debt obligations comfortably. This underscores a balanced approach to growth and financial stability.
Yamada maintains a solid balance sheet, with ¥4.53 billion in cash and equivalents against ¥1.73 billion in total debt, yielding a conservative net cash position. This liquidity cushion supports flexibility for strategic initiatives or downturns. The absence of excessive leverage reinforces its financial health, aligning with its low-risk profile in the industrials sector.
The company’s growth appears steady rather than explosive, with a focus on incremental innovation and market penetration. A dividend per share of ¥210 signals a shareholder-friendly policy, though payout ratios remain sustainable given earnings stability. Future growth may hinge on expanding its medical equipment segment and international sales channels.
With a market cap of ¥11.77 billion, Yamada trades at a P/E ratio of approximately 6.5x, suggesting modest market expectations. The low beta and niche positioning may appeal to value-oriented investors, though limited revenue growth visibility could temper premium valuations. The stock’s pricing reflects its stable but unspectacular growth trajectory.
Yamada’s longevity and technical expertise in fluid control systems provide a competitive moat. Its diversification into medical equipment and maintenance services offers growth optionality. Near-term challenges include industrial demand cyclicality, but its strong balance sheet and cash flow resilience position it well for sustained performance. Strategic focus on high-margin segments and global expansion could drive incremental value.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |